BioXplor is developing an AI and network-based drug discovery platform for prioritization of drug combinations for complex diseases for pharma and biotech. The platform prioritises single assets or entire drug pipelines, with a unique safety and efficacy based prioritization model for multiple drug targets and drug combination candidates. In response to the pandemic, BioXplor is positioning the platform for antiviral and anti-inflammatory COVID-19 drug combinations, and is leveraging this to build a pipeline of biotech and academic partners and clients.
CDL Recovery – Some Lessons Learned
The CDL Recovery program provided a rich set of learning opportunities. Participants gained insights into the trade-offs that companies face when developing a Covid strategy alongside their core business. CDL Recovery showcased CDL's global community of mentors and experts that is deeply committed to supporting innovative entrepreneurs.